These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15055161)

  • 21. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Lee KH; Choi SJ; Lee JH; Lee JS; Kim WK; Lee KB; Sohn SK; Kim JG; Kim DH; Seol M; Lee YS; Lee JH
    Haematologica; 2005 Jul; 90(7):939-48. PubMed ID: 15996932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion-associated graft-versus-host disease.
    Dwyre DM; Holland PV
    Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma].
    García Gala JM; Ramírez Páyer A; Rayón C; Rodríguez Vicente P; Rosón C; Blanco C
    Sangre (Barc); 1993 Dec; 38(6):489-91. PubMed ID: 8171385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
    Law LY; Horning SJ; Wong RM; Johnston LJ; Laport GG; Lowsky R; Shizuru JA; Blume KG; Negrin RS; Stockerl-Goldstein KE
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):703-11. PubMed ID: 16785059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary osteochondrorhabdomyosarcoma (malignant mesenchymoma) of the fibula: a rare tumour in an unusual site -- case report and review of the literature.
    Chow LT; Kumta SM
    APMIS; 2004 Sep; 112(9):617-23. PubMed ID: 15601312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion-associated graft-versus-host disease.
    Rühl H; Bein G; Sachs UJ
    Transfus Med Rev; 2009 Jan; 23(1):62-71. PubMed ID: 19056035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute graft-versus-host disease in pancreas transplantation: a comparison of two case presentations and a review of the literature.
    Weinstein A; Dexter D; KuKuruga DL; Philosophe B; Hess J; Klassen D
    Transplantation; 2006 Jul; 82(1):127-31. PubMed ID: 16861952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late onset of severe graft-versus-host disease following liver transplantation.
    Sun B; Zhao C; Xia Y; Li G; Cheng F; Li J; Zhang F; Wang X
    Transpl Immunol; 2006 Nov; 16(3-4):250-3. PubMed ID: 17138062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; conversion to full donor chimerism.
    Jillella AP; Shafer D; Klumpp TR; Emmons RV; Mangan KF
    Am J Hematol; 2007 Jun; 82(6):419-26. PubMed ID: 17211845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis.
    Russell JA; Turner AR; Larratt L; Chaudhry A; Morris D; Brown C; Quinlan D; Stewart D
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):299-306. PubMed ID: 17317583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature.
    Agbaht K; Altintas ND; Topeli A; Gokoz O; Ozcebe O
    Transfusion; 2007 Aug; 47(8):1405-11. PubMed ID: 17655584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
    Pabst C; Schirutschke H; Ehninger G; Bornhäuser M; Platzbecker U
    Clin Cancer Res; 2007 May; 13(10):2916-22. PubMed ID: 17504991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How do we prevent transfusion-associated graft-versus-host disease in children?
    King KE; Ness PM
    Transfusion; 2011 May; 51(5):916-20. PubMed ID: 21235596
    [No Abstract]   [Full Text] [Related]  

  • 35. Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation.
    Tanoshima R; Goto H; Yanagimachi M; Kajiwara R; Kuroki F; Yokota S
    Pediatr Blood Cancer; 2008 Mar; 50(3):665-7. PubMed ID: 17437289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor.
    Ryo R; Saigo K; Hashimoto M; Kohsaki M; Yasufuku M; Watanabe N; Okada M; Tadokoro K; Juji T
    Vox Sang; 1999; 76(4):241-6. PubMed ID: 10394145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.
    Huff CA; Fuchs EJ; Smith BD; Blackford A; Garrett-Mayer E; Brodsky RA; Flinn IW; Ambinder RF; Borrello IM; Matsui WH; Vogelsang GB; Griffin CA; Luznik L; Jones RJ
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):414-21. PubMed ID: 16545725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anterior uveitis: a manifestation of graft-versus-host disease.
    Hettinga YM; Verdonck LF; Fijnheer R; Rijkers GT; Rothova A
    Ophthalmology; 2007 Apr; 114(4):794-7. PubMed ID: 17187864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probable transfusion-associated graft-versus-host disease in a patient with tuberous sclerosis.
    Asnis DS; Wasil T; Chaudri F; Kuan J
    South Med J; 1996 Apr; 89(4):446-8. PubMed ID: 8614894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.